Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor beta-deficient mice.
Peroxisome proliferator-activated receptors (PPARs) are involved in energy expenditure, regulation of inflammatory processes, and cellular protection in peripheral tissues. Among the different types of PPARs, PPARbeta is the only one to be widely expressed in cortical neurons. Using PPARbeta knockout (KO) mice, we report here a detailed investigation of the role of PPARbeta in cerebral ischemic damage, associated inflammatory and antioxidant processes as well as food intake regulation after middle cerebral artery occlusion (MCAO). The PPARbeta KO mice had a two-fold increase in infarct size compared with wild-type (WT) mice. Brain oxidative stress was dramatically enhanced in these KO mice, as documented by an increased content of malondialdehyde, decreased levels of glutathione and manganese superoxide dismutase, and no induction of uncoupling protein 2 (UCP2) mRNA. Unlike WT mice, PPARbeta KO mice showed a marked increase of prooxidant interferon-gamma but no induction of nerve growth factor and tumor necrosis factor alpha after MCAO. In WT mice, MCAO resulted in inflammation-specific transient hyperphagia from day 3 to day 5 after ischemia, which was associated with an increase in neuropeptide Y (NPY) mRNA. This hyperphagic phase and NPY mRNA induction were not observed in PPARbeta KO mice. Furthermore, our study also suggests for the first time that UCP2 is involved in MCAO food intake response. These data indicate that PPARbeta plays an important role in integrating and regulating central inflammation, antioxidant mechanisms, and food intake after MCAO, and suggest that the use of PPARbeta agonists may be of interest for the prevention of central ischemic damage.
Arsenijevic
Denis
D
Institute of Animal Sciences, ETHZ, Zurich, Switzerland. denis.arsenijevic@inw.agrl.ethz.ch
de Bilbao
Fabienne
F
Plamondon
Julie
J
Paradis
Eric
E
Vallet
Philippe
P
Richard
Denis
D
Langhans
Wolfgang
W
Giannakopoulos
Panteleimon
P
D000818:Animals; D002545:Brain Ischemia / Q000150:complications / Q000503:physiopathology*; D002544:Cerebral Infarction / Q000209:etiology / Q000503:physiopathology*; D004195:Disease Models, Animal; D020869:Gene Expression Profiling; D005978:Glutathione / Q000187:drug effects / Q000378:metabolism; D006963:Hyperphagia / Q000209:etiology / Q000503:physiopathology*; D020244:Infarction, Middle Cerebral Artery / Q000150:complications / Q000503:physiopathology; D007371:Interferon-gamma / Q000494:pharmacology; D007473:Ion Channels; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D008297:Male; D026901:Membrane Transport Proteins / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D024101:Mitochondrial Proteins / Q000235:genetics; D020932:Nerve Growth Factor / Q000494:pharmacology; D009478:Neuropeptide Y / Q000235:genetics / Q000378:metabolism; D048068:PPAR-beta / Q000172:deficiency* / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D013482:Superoxide Dismutase / Q000187:drug effects; D000071246:Uncoupling Protein 2
D007473:Ion Channels; D026901:Membrane Transport Proteins; D024101:Mitochondrial Proteins; D009478:Neuropeptide Y; D048068:PPAR-beta; D012333:RNA, Messenger; C000604390:Ucp2 protein, mouse; D000071246:Uncoupling Protein 2; D007371:Interferon-gamma; D020932:Nerve Growth Factor; D013482:Superoxide Dismutase; D005978:Glutathione